Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 April 2011: Basic Research  

Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats

Osama M. Ashour ABCDEF , Ahmed A. Elberry ABCDEF , Abdulrahman Alahdal E , Ameen M. Al Mohamadi E , Ayman A. Nagy BD , Ashraf B. Abdel-Naim ABCDEF , Essam A. Abdel-Sattar BD , Ahmed M. Mohamadin BD

DOI: 10.12659/MSM.881711

Med Sci Monit 2011; 17(4): BR110-115

0 Comments

Background

Doxorubicin (DOX) is an anthracycline antibiotic used widely in treatment of various malignancies, including acute leukemias, malignant lymphomas, and a variety of solid tumors. However, the occurrence of cardiotoxicity as a major side effect limits its use [1,2]. Although numerous mechanisms have been proposed, most studies implicate increased oxidative stress [3–5]. The idea that reactive oxygen species (ROS) plays a role is supported by the findings that treatment of animals with a variety of antioxidants protects against DOX-induced cardiotoxicity [6,7].

Blueberries belong to the genus Vaccinium, a widespread genus with over 200 species. The prominent species are the North-American highbush (Vaccinium corymbosum) and lowbush (Vaccinium angustifolium) blueberries, together with the native European blueberry, also called bilberry (Vaccinium myrtillus). In Northern Europe, bilberry is one of the most important wild berries. Bilberry is known to have a high content of anthocyanins, flavonoids and phenolic acids [7]. Anthocyanins, flavonoids and other phenolic compounds are reported to have multiple biological effects including antioxidant, antimutagenic, anticarcinogenic, anti-inflammatory, antihypertensive, antihyperlipidemic, antiproliferative and antimicrobial activities [8–12]. Further, bilberry fruit was reported to possess strong antiradical activity [13]. Recently, we showed that cranberry (Vaccinium macrocarpon), which contains flavonoids and phenolic acids, protects against DOX-induced cardiotoxicity in rats [14]. Therefore, the present study was designed to explore the potential protective effects of the alcoholic extract of bilberry “Vaccinium myrtillus” against DOX-induced cardiotoxicity in rats.

Material and Methods

DOX was obtained as doxorubicin hydrochloride (2 mg/ml) from EBWE Pharma, A-4866 Unterach, Austria. Bilberry (Vaccinium myrtillus) capsules were purchased from GNC products (bilberry 100 Capsules, USA). Each capsule contained 100 mg of lyophilized powdered fruits. The powdered fruit content of 100 capsules (equivalent to 10 g) was extracted with 90% MeOH (3×150 ml) by using ultra-turrex T25 homogenizer (Janke and Kunkel, IKA Labortechnik, Stauten, Germany) at a temperature not exceeding 25°C, using an ice bath. The extract was evaporated under reduced pressure, lyophilized, and protected from light at −4°C until use. The extract was analyzed by thin layer chromatography as fingerprint using the chromatographic system reported by Camag (http://www.camag.com, last visited 10/8/2010). All other chemicals were purchased from Sigma-Aldrich Chemical Company (St Louis, MO, USA).

Male Wistar rats, weighing 250–300 g, were obtained from the animal facility of King Fahd Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. They were used in the study according to the guidelines of the Biochemical and Research Ethics Committee at King Abdulaziz University. Animals were housed in a well-ventilated, temperature-controlled room at 22±3°C with a 12 h light-dark cycle. They were provided with a balanced commercial diet and tap water. All experimental procedures were performed between 8–10 a.m. and care was taken to avoid stressful conditions.

Rats were randomly divided into 4 groups (12 animals in each group). Group I received carboxymethylcellulose (CMC; 0.5%) (1 ml/200 g body weight/day) orally for 10 consecutive days. Group II received bilberry alone suspended in 0.5% CMC (100 mg/kg; orally once daily for 10 consecutive days). The dose of bilberry was chosen according to pilot experiments conducted by our research group. Group III received CMC orally for 10 consecutive days and a single dose of DOX (15 mg/kg, i.p.) on day 7 [15]. Group IV received both bilberry and DOX in the previously mentioned doses; bilberry was administered for 10 consecutive days and DOX was administered once on day 7.

Twenty-four hours after the last bilberry or CMC treatment (day 11), rats were anesthetized with thiopentone (35 mg/kg; i.p.) and subjected to ECG recording. Blood samples (2–3 ml each) were collected by orbital puncture and were centrifuged for 10 minutes at 3000 ×g at room temperature to separate the sera for biochemical analyses. The abdomen of each rat was opened and the heart were rapidly dissected out, washed in ice-cold isotonic saline and blotted between 2 filter papers. Six hearts from each group were fixed in 10% formalin for histopathological examination, and the remaining hearts from each group were homogenized in ice-cold 0.1 M potassium phosphate puffer (pH 7.4) for subsequent analyses.

ECG was recorded in thiopentone anesthetized rats using the Bioscience ECG recorder (Bioscience, Washington, USA). Needle electrodes were inserted under the skin for the limb lead at position II. Paper speed was 50 mm/sec and the voltage was 1 mV/cm. Noise was minimized by a digital filter.

Reduced glutathione (GSH) content was determined according to the method of Adams et al. [16], and oxidized glutathione (GSSG) level was assessed according to the method of Hissin and Hilf [17] (values are expressed as nmol/mg protein). Lipid peroxidation was determined by measuring thiobarbituric acid reactive substances (TBARS) in tissue homogenates referring to the malondialdehyde (MDA) standard calibration curve according to the method of Uchiyama and Mihara [18] (values are expressed as nmol/g protein). Catalase (CAT) activity was determined according to the method described by Aebi [19] based on determination of the H2O2 decomposition rate at 240 nm (values are expressed as U/mg protein). Superoxide dismutase (SOD) activity was determined according to the method of Sun et al. [20] based on inhibition of nitroblue-tetrazolium reduction by the xanthine-xanthine oxidase system as a superoxide generator (values are expressed as U/mg protein). Glutathione peroxidase (GSH-Px) activity was assessed spectrophotometrically according to the method of Paglia and Valentine [21] (values are expressed as U/mg protein). Myeloperoxidase (MPO) activity was determined by the method of Wei and Frenkel [22] based on using 4-aminoantipyrine/phenol solution as the substrate for MPO-mediated oxidation by H2O2 and recording the changes in absorbance at 510 nm (values are expressed as mU/g protein). Protein carbonyl content (PCC) was determined spectrophotometrically by a method based on the reaction of the carbonyl group with 2,4-dinitrophenylhydrazine to form 2,4-dinitrophenylhydrazone [23] (values are expressed as nanomoles carbonyl/mg protein). The protein content of cardiac tissue homogenates was determined by the Lowry protein assay, using bovine serum albumin as the standard [24].

Creatine phosphokinase (CPK), creatine kinase isoenzyme-MB (CK-MB) and lactate dehydrogenase (LDH) activities were determined according to standard methods, using diagnostic kits from BioSystems S.A. (Barcelona, Spain). Assessment of serum troponin I was carried out by enzyme-linked immunosorbent assay (ELISA) using a kit purchased from DRG International Inc. (Mountainside, NJ, USA).

Hearts were cut at 0.5 μm, mounted on slides, stained with hematoxylin and eosin (H&E) and examined under light microscope (Olympus BX-50 Olympus Corporation, Tokyo, Japan).

Results are expressed as means ±SEM. Assessment of these results was performed using one-way analysis of variance (ANOVA), followed by Tukey-Kramer test for multiple comparisons using GraphPad InStat software, Version 4 (GraphPad Software Inc, La Jolla, CA, USA). The statistical significance was accepted at a level of P<0.05.

Results

ECG tracing showed normal cardiac activity in all rats in the control and bilberry groups, with a mean heart rate of 366±12 and 360±15 beat/min, respectively. Rats in the DOX-only treated group showed bradycardia (254±14 beat/min), ST segment depression and prolongation of both ST and QT intervals. Such ECG abnormalities were clearly improved in the bilberry+DOX group, as evidenced by normalization of heart rate, ST segment, and both ST and QT intervals (Table 1 and Figure 1).

Cardiac content of GSH was significantly reduced in the DOX-only treated group as compared with the control group. Animals in the bilberry+DOX group showed significantly higher levels of GSH as compared to DOX-treated animals. However, GSH level in the bilberry+DOX group was still significantly lower than in the control group. Cardiac levels of GSSG, MDA and protein carbonyl contents were increased significantly in the DOX-only treated group compared with the control group. Bilberry pretreatment significantly guarded against elevations in the latter parameters. Although not normalized, GSSG and MDA levels were significantly lower than the corresponding values in the DOX group. In addition, premedication with bilberry restored the DOX-elevated PCC to the control value (Table 2).

Administration of DOX to rats significantly reduced the cardiac activities of CAT, SOD, and GSH-Px as compared to the control group. The drop in CAT activity caused by DOX treatment was not influenced by bilberry pretreatment, while the activities of SOD and GSH-Px in the bilberry+DOX group were significantly restored to near control values (Table 3). Assessment of MPO activity in cardiac tissues indicated a significant increase in the DOX-only treated group. Pretreatment with bilberry exerted a significant reduction compared to DOX-only treated group, and still significantly higher than the control group (Table 3).

The serum markers indicating myocardial injury (LDH, CPK, CK-MB and troponin I) were significantly elevated in the DOX-only treated group compared with the control and bilberry-only treated group. Pretreatment with bilberry in the bilberry+DOX group significantly reduced their levels as compared with the DOX-only treated group, but were not restored to their corresponding control values (Figure 2).

Hearts from control and bilberry groups showed normal cell distribution and myocardium architecture (Figure 3A, B). Hearts from DOX-only treated rats revealed severe vacuolar degeneration and interstitial edema (Figure 3C). These pathological alterations were markedly ameliorated in animals from the bilberry+DOX group, with mild congestion and some interstitial edema (Figure 3D).

Discussion

Despite the development of several antitumor drugs, DOX continues to be an effective and widely used broad spectrum chemotherapeutic agent; however, its use is limited because of its serious dose-dependent cardiotoxicity [25]. Previous studies have suggested that the generation of free radicals and depletion of endogenous antioxidants induced by DOX are involved in the mechanism of DOX-induced cardiotoxicity [3,26,27]. Inhibiting generation of ROS by antioxidants, as well as the iron chelating agent dexrazoxane, have been shown to ameliorate DOX cardiotoxicity [28]. The present study was designed to investigate the potential protective effects of bilberry extract against DOX-induced cardiotoxicity in rats.

ECG tracing of rats in the DOX group showed bradycardia, ST segment depression and prolongation of both ST and QT intervals, which reflected arrhythmias, conduction abnormalities and attenuation of left ventricular function. Similar changes have been reported by other investigators [15,29–31]. These ECG changes were ameliorated in the bilberry+DOX group, indicating the protective effect of bilberry.

Our data show that cardiac levels of GSSG, MDA and PCC were significantly elevated, while those of GSH were significantly reduced following DOX administration as compared to the control group. Clearly, these data indicate the occurrence of oxidative stress, which is in accordance with reports of previous studies [32,33]. The reduced GSH and the elevated GSSG levels in the DOX group might be due to GSH consumption in the interactions of DOX-induced free radicals with bio-membrane and the subsequent lipid peroxidation. Pretreatment of rats with bilberry significantly guarded against the oxidative stress observed in the DOX group. Furthermore, the activity of the cardiac antioxidant enzymes CAT, SOD and GSH-Px were significantly reduced, while that of MPO was significantly elevated in response to DOX administration as compared to the control group. These data are in accord with those reported by many investigators [34,35]. Our results also indicate that bilberry alleviated the decrease of the activity of the antioxidant enzymes, and can be explained by its high content of several antioxidants including anthocyanine, flavonoids and phenolic acids [7]. These compounds were reported to inhibit oxidative processes in other tissues [36]. They have been shown to effectively scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide [37], improve the ferric-reducing antioxidant power in plasma [38] and suppress the DNA damage induced by DOX [39]. Moreover, Li et al. [31] reported that procyanidins from grape seeds protected rats from DOX-induced myocardial damage and cardiac dysfunction by scavenging the free radical. The increased MPO activity in the DOX group denotes leukocyte accumulation, with subsequent oxidative injury in cardiac tissue [40,41]. Despite the positive effects of flavonoids in experimental models of DOX cardiotoxicity, clinical trials have shown little success [42].

Conclusions

Regarding serum biochemical parameters, DOX significantly elevated serum LDH activity and CPK, CK-MB and troponin I levels; all of which indicate cardiac injury [43]. Similar observations were previously reported by Shi et al. [44] and Iqbal et al. [45]. Bilberry, in the present study, significantly inhibited DOX-induced elevations in serum activity of LDH, CPK and CK-MB, as well as troponin I levels. Histopathological examination showed cardiac injury in the DOX group in the form of cytoplasmic vacuole formation, interstitial edema and vascular degeneration, typically present in acute DOX-induced cardiotoxicity in rats [46,47] and mice [48]. The severity of the histological changes was much less in sections from rats pretreated with bilberry. According to the results of the present study, it can be concluded that bilberry protects against DOX-induced cardiotoxicity in rats, which can be attributed, at least in part, to its antioxidant activity.

References

1. Shan K, Lincoff AM, Young JB, Anthracycline-induced cardiotoxicity: Ann Intern Med, 1996; 125; 47-58, pmid: 8644988

2. Hortobagyi GN, Anthracyclines in the treatment of cancer. An overview: Drugs, 1997; 54; 1-7, pmid: 9361955

3. Myers C, Bonow R, Palmeri S, A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine: Semin Oncol, 1983; 10; 53-55, pmid: 6340204

4. Singal PK, Segstro RJ, Singh RP, Kutryk MJ, Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy: Can J Cardiol, 1985; 1; 139-47, pmid: 3931886

5. Singal PK, Deally CM, Weinberg LE, Subcellular effects of adriamycin in the heart: a concise review: J Mol Cell Cardiol, 1987; 19; 817-28, pmid: 3320376

6. Nazeyrollas P, Prévost A, Baccard N, Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity: Cancer Chemother Pharmacol, 1999; 43; 227-32, pmid: 9923553

7. Liu X, Chen Z, Chua CC, Melatonin as an effective protector against doxorubicin-induced cardiotoxicity: Am J Physiol Heart Circ Physiol, 2002; 283; H254-63, pmid: 12063298

8. Morton LW, Abu-Amsha Caccetta R, Puddey IB, Croft KD, Chemistry and biological effects of dietary phenolic compounds: Relevance to cardiovascular disease: Clin Exp Pharmacol Physiol, 2000; 27(3); 152-59, pmid: 10744340

9. Tapiero H, Tew KD, Ba GN, Mathé G, Polyphenols: Do they play a role in the prevention of human pathologies?: Biomed Pharmacother, 2002; 56(4); 200-7, pmid: 12109813

10. Devi A, Jolitha AB, Ishii N, Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats: Med Sci Monit, 2006; 12(4); 124-29

11. Heinonen M, Antioxidant activity and antimicrobial effect of berry phenolics – a finnish perspective: Mol Nutr Food Res, 2007; 51(6); 684-91, pmid: 17492800

12. Broneel M, Kozirog M, Duchnowicz P, Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker level in patients with metabolic syndrome: Med Sci Monit, 2010; 16(1); CR28-34, pmid: 20037491

13. Burdulis D, Sarkinas A, Jasutiené I: Acta Pol Pharm, 2009; 66(4); 399-408, pmid: 19702172

14. Elberry AA, Abdel-Naim AB, Abdel-Sattar EA: Food Chem Toxicol, 2010(48); 1178-84, pmid: 20146931

15. Fadillioglu E, Oztas E, Erdogan H, Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats: J Appl Toxicol, 2004; 24; 47-52, pmid: 14745846

16. Adams JD, Lauterburg BH, Mitchell JR, Plasma glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress: J Pharmacol Exp Ther, 1983; 227; 749-54, pmid: 6655568

17. Hissin PJ, Hilf RA, A fluorometric method for determination of oxidized and reduced glutathione in tissues: Anal Biochem, 1976; 74; 214-26, pmid: 962076

18. Uchiyama M, Mihara M, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test: Anal Biochem, 1978; 86; 271-78, pmid: 655387

19. Aebi H: Methods in Enzymology, 1984; 105; 121-26, New York, Academic Press

20. Sun Y, Oberley LW, Li Y, A simple method for clinical assay of superoxide dismutase: Clin Chem, 1988; 34; 497-500, pmid: 3349599

21. Paglia DE, Valentine WN, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase: J Lab Clin Med, 1967; 70; 158-69, pmid: 6066618

22. Wei H, Frenkel K: Carcinogenesis, 1993; 14; 1195-201, pmid: 8508507

23. Levine RL, Garland D, Oliver CN, Determination of carbonyl content in oxidatively modified proteins: Methods in Enzymology, V 186, Oxygen radicals in Biological Systems, 1990; 464-78, New York, Academic Press

24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, Protein measurement with the Folin phenol reagent: J Biol Chem, 1951; 193; 265-75, pmid: 14907713

25. Singal PK, Iliskovic N, Doxorubicin-induced cardiomyopathy: N Engl J Med, 1998; 339; 900-5, pmid: 9744975

26. Franco F, Dubois SK, Peshock RM, Shohet RV, Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy: Am J Physiol Heart Circ Physiol, 1998; 274; H679-83

27. Takemura G, Fujiwara H, Doxorubicin-induced cardiomyopathy from Cardiotoxic mechanisms to management: Prog Cardiovasc Dis, 2007; 49; 330-52, pmid: 17329180

28. Šimùnek T, Štìrba M, Popelová O, Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron: Pharmacol Rep, 2009; 61; 154-71, pmid: 19307704

29. Larsen RL, Jakacki RI, Vetter VL, Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults: Am J Cardiol, 1992; 70; 73-77, pmid: 1615874

30. Puri A, Maulik SK, Ray R, Bhatnagar V, Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats: Eur J Pediatr Surg, 2005; 15; 387-91, pmid: 16418954

31. Li W, Xu B, Xu J, Wu XL, Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress: Basic Clin Pharmacol Toxicol, 2009; 104; 192-97, pmid: 19143757

32. Choi EH, Lee N, Kim HJ, Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes: Genes Nutr, 2008; 2; 337-45, pmid: 18850228

33. Ibrahim MA, Ashour OM, Ibrahim YF, Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity: Pharmacol Res, 2009; 60(5); 373-81, pmid: 19467331

34. Dbrowska K, Stuss M, Gromadzińska J, The effects of melatonin on glutathione peroxidase activity in serum and erythrocytes after adriamycin in normal and pinealectomised rats: Endokrynol Pol, 2008; 59(3); 200-6, pmid: 18615393

35. Tatlidede E, Sehirli O, Velioğlu-Oğünc A, Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage: Free Radic Res, 2009; 43; 195-205, pmid: 19169920

36. Ofek I, Goldhar J, Zafriri D, Anti-Escherichia coli adhesin activity of cranberry and blueberry juices: N Engl J Med, 1991; 324(22); 1599, pmid: 1674106

37. Chang WT, Shao ZH, Yin JJ, Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes: Eur J Pharmacol, 2007; 566; 58-66, pmid: 17475241

38. Busserolles J, Gueux E, Balasińska B: Int J Vitam Nutr Res, 2006; 76; 22-27, pmid: 16711653

39. de Rezende AA, Graf U, da Guterres ZR: Food Chem Toxicol, 2009; 47; 1466-72, pmid: 19341778

40. Riad A, Bien S, Westermann D, Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice: Cancer Res, 2009; 69(2); 695-99, pmid: 19147586

41. Arnhold J, Osipov AN, Spalteholz H, Effects of hypochlorous acid on unsaturated phosphatidylcholines: Free Radic Biol Med, 2001; 31(9); 1111-19, pmid: 11677044

42. Bruynzeel AME, Niessen HWM, Bronzwaer JGF, The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study: Br J Cancer, 2007; 97; 1084-89, pmid: 17940501

43. Herman E, Mhatre R, Lee IP, Comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys: Pharmacology, 1971; 6; 230-41, pmid: 5002849

44. Shi R, Liu L, Huo Y, Cheng YY: Zhongguo Zhong Yao Za Zhi, 2007; 32(24); 2632-35, pmid: 18338604

45. Iqbal M, Dubey K, Anwer T, Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats: Pharmacol Rep, 2008; 60(3); 382-90, pmid: 18622063

46. Morishima I, Matsui H, Mukawa H, Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats: Life Sci, 1998; 63; 511-21, pmid: 9718077

47. Mukherjee S, Banerjee SK, Maulik M, Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression: BMC Pharmacol, 2003; 3; 16, pmid: 14687418

48. Xin YF, Zhou GL, Shen M, Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity: Basic Clin Pharmacol Toxicol, 2007; 101; 421-26, pmid: 17971065

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750